Selected research
Market Analysis & Forecast
Global Immunology Testing Services Market Analysis and Forecast 2026-2032
Market perspective
The global Immunology Testing Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The North America market for Immunology Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Immunology Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Immunology Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Immunology Testing Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global companies of Immunology Testing Services include KMD Biotechnology (Tianjin) Co., Ltd., Certimmune, Charles River Laboratories, EpiVax, Viroclinics Biosciences, SYNLAB, ICON plc, Qingdao Kechuang Quality Inspection Co., Ltd. and Standard Testing Group Co., Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Immunology Testing Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Immunology Testing Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Immunology Testing Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Immunology Testing Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Immunology Testing Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Immunology Testing Services revenue, projected growth trends, production technology, application and end-user industry.
Immunology Testing Services Segment by Company
KMD Biotechnology (Tianjin) Co., Ltd.
Certimmune
Charles River Laboratories
EpiVax
Viroclinics Biosciences
SYNLAB
ICON plc
Qingdao Kechuang Quality Inspection Co., Ltd.
Standard Testing Group Co., Ltd.
Nanjing Keyi Biotechnology Co., Ltd.
Immunology Testing Services Segment by Type
Antibody Detection
autoantibody Detection
Immune Cell Detection
Immunohistochemical detection
Others
Immunology Testing Services Segment by Application
Medical Industry
Environmental Industry
Agriculture
Immunology Testing Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunology Testing Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immunology Testing Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunology Testing Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Immunology Testing Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Immunology Testing Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Immunology Testing Services revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antibody Detection
- autoantibody Detection
- Immune Cell Detection
- Immunohistochemical detection
- Others
Applications
- Medical Industry
- Environmental Industry
- Agriculture
Companies covered
- KMD Biotechnology (Tianjin) Co., Ltd.
- Certimmune
- Charles River Laboratories
- EpiVax
- Viroclinics Biosciences
- SYNLAB
- ICON plc
- Qingdao Kechuang Quality Inspection Co., Ltd.
- Standard Testing Group Co., Ltd.
- Nanjing Keyi Biotechnology Co., Ltd.
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Immunology Testing Services Market by Type
- 1.2.1 Global Immunology Testing Services Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 Antibody Detection
- 1.2.3 autoantibody Detection
- 1.2.4 Immune Cell Detection
- 1.2.5 Immunohistochemical detection
- 1.2.6 Others
- 1.3 Immunology Testing Services Market by Application
- 1.3.1 Global Immunology Testing Services Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Medical Industry
- 1.3.3 Environmental Industry
- 1.3.4 Agriculture
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Immunology Testing Services Market Dynamics
- 2.1 Immunology Testing Services Industry Trends
- 2.2 Immunology Testing Services Industry Drivers
- 2.3 Immunology Testing Services Industry Opportunities and Challenges
- 2.4 Immunology Testing Services Industry Restraints
3 Global Growth Perspective
- 3.1 Global Immunology Testing Services Market Perspective (2021-2032)
- 3.2 Global Immunology Testing Services Growth Trends by Region
- 3.2.1 Global Immunology Testing Services Market Size by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Immunology Testing Services Market Size by Region (2021-2026)
- 3.2.3 Global Immunology Testing Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
- 4.1 Global Immunology Testing Services Revenue by Players
- 4.1.1 Global Immunology Testing Services Revenue by Players (2021-2026)
- 4.1.2 Global Immunology Testing Services Revenue Market Share by Players (2021-2026)
- 4.1.3 Global Immunology Testing Services Players Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Immunology Testing Services Key Players Ranking, 2024 VS 2025 VS 2026
- 4.3 Global Immunology Testing Services Key Players Headquarters & Area Served
- 4.4 Global Immunology Testing Services Players, Product Type & Application
- 4.5 Global Immunology Testing Services Players Establishment Date
- 4.6 Market Competitive Analysis
- 4.6.1 Global Immunology Testing Services Market CR5 and HHI
- 4.6.3 2025 Immunology Testing Services Tier 1, Tier 2, and Tier 3
5 Immunology Testing Services Market Size by Type
- 5.1 Global Immunology Testing Services Revenue by Type (2021 VS 2025 VS 2032)
- 5.2 Global Immunology Testing Services Revenue by Type (2021-2032)
- 5.3 Global Immunology Testing Services Revenue Market Share by Type (2021-2032)
6 Immunology Testing Services Market Size by Application
- 6.1 Global Immunology Testing Services Revenue by Application (2021 VS 2025 VS 2032)
- 6.2 Global Immunology Testing Services Revenue by Application (2021-2032)
- 6.3 Global Immunology Testing Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
- 7.1 KMD Biotechnology (Tianjin) Co., Ltd.
- 7.1.1 KMD Biotechnology (Tianjin) Co., Ltd. Company Information
- 7.1.2 KMD Biotechnology (Tianjin) Co., Ltd. Business Overview
- 7.1.3 KMD Biotechnology (Tianjin) Co., Ltd. Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 7.1.4 KMD Biotechnology (Tianjin) Co., Ltd. Immunology Testing Services Product Portfolio
- 7.1.5 KMD Biotechnology (Tianjin) Co., Ltd. Recent Developments
- 7.2 Certimmune
- 7.2.1 Certimmune Company Information
- 7.2.2 Certimmune Business Overview
- 7.2.3 Certimmune Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 7.2.4 Certimmune Immunology Testing Services Product Portfolio
- 7.2.5 Certimmune Recent Developments
- 7.3 Charles River Laboratories
- 7.3.1 Charles River Laboratories Company Information
- 7.3.2 Charles River Laboratories Business Overview
- 7.3.3 Charles River Laboratories Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 7.3.4 Charles River Laboratories Immunology Testing Services Product Portfolio
- 7.3.5 Charles River Laboratories Recent Developments
- 7.4 EpiVax
- 7.4.1 EpiVax Company Information
- 7.4.2 EpiVax Business Overview
- 7.4.3 EpiVax Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 7.4.4 EpiVax Immunology Testing Services Product Portfolio
- 7.4.5 EpiVax Recent Developments
- 7.5 Viroclinics Biosciences
- 7.5.1 Viroclinics Biosciences Company Information
- 7.5.2 Viroclinics Biosciences Business Overview
- 7.5.3 Viroclinics Biosciences Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 7.5.4 Viroclinics Biosciences Immunology Testing Services Product Portfolio
- 7.5.5 Viroclinics Biosciences Recent Developments
- 7.6 SYNLAB
- 7.6.1 SYNLAB Company Information
- 7.6.2 SYNLAB Business Overview
- 7.6.3 SYNLAB Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 7.6.4 SYNLAB Immunology Testing Services Product Portfolio
- 7.6.5 SYNLAB Recent Developments
- 7.7 ICON plc
- 7.7.1 ICON plc Company Information
- 7.7.2 ICON plc Business Overview
- 7.7.3 ICON plc Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 7.7.4 ICON plc Immunology Testing Services Product Portfolio
- 7.7.5 ICON plc Recent Developments
- 7.8 Qingdao Kechuang Quality Inspection Co., Ltd.
- 7.8.1 Qingdao Kechuang Quality Inspection Co., Ltd. Company Information
- 7.8.2 Qingdao Kechuang Quality Inspection Co., Ltd. Business Overview
- 7.8.3 Qingdao Kechuang Quality Inspection Co., Ltd. Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 7.8.4 Qingdao Kechuang Quality Inspection Co., Ltd. Immunology Testing Services Product Portfolio
- 7.8.5 Qingdao Kechuang Quality Inspection Co., Ltd. Recent Developments
- 7.9 Standard Testing Group Co., Ltd.
- 7.9.1 Standard Testing Group Co., Ltd. Company Information
- 7.9.2 Standard Testing Group Co., Ltd. Business Overview
- 7.9.3 Standard Testing Group Co., Ltd. Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 7.9.4 Standard Testing Group Co., Ltd. Immunology Testing Services Product Portfolio
- 7.9.5 Standard Testing Group Co., Ltd. Recent Developments
- 7.10 Nanjing Keyi Biotechnology Co., Ltd.
- 7.10.1 Nanjing Keyi Biotechnology Co., Ltd. Company Information
- 7.10.2 Nanjing Keyi Biotechnology Co., Ltd. Business Overview
- 7.10.3 Nanjing Keyi Biotechnology Co., Ltd. Immunology Testing Services Revenue and Gross Margin (2021-2026)
- 7.10.4 Nanjing Keyi Biotechnology Co., Ltd. Immunology Testing Services Product Portfolio
- 7.10.5 Nanjing Keyi Biotechnology Co., Ltd. Recent Developments
8 North America
- 8.1 North America Immunology Testing Services Revenue (2021-2032)
- 8.2 North America Immunology Testing Services Revenue by Type (2021-2032)
- 8.2.1 North America Immunology Testing Services Revenue by Type (2021-2026)
- 8.2.2 North America Immunology Testing Services Revenue by Type (2027-2032)
- 8.3 North America Immunology Testing Services Revenue Share by Type (2021-2032)
- 8.4 North America Immunology Testing Services Revenue by Application (2021-2032)
- 8.4.1 North America Immunology Testing Services Revenue by Application (2021-2026)
- 8.4.2 North America Immunology Testing Services Revenue by Application (2027-2032)
- 8.5 North America Immunology Testing Services Revenue Share by Application (2021-2032)
- 8.6 North America Immunology Testing Services Revenue by Country
- 8.6.1 North America Immunology Testing Services Revenue by Country (2021 VS 2025 VS 2032)
- 8.6.2 North America Immunology Testing Services Revenue by Country (2021-2026)
- 8.6.3 North America Immunology Testing Services Revenue by Country (2027-2032)
- 8.6.4 United States
- 8.6.5 Canada
- 8.6.6 Mexico
9 Europe
- 9.1 Europe Immunology Testing Services Revenue (2021-2032)
- 9.2 Europe Immunology Testing Services Revenue by Type (2021-2032)
- 9.2.1 Europe Immunology Testing Services Revenue by Type (2021-2026)
- 9.2.2 Europe Immunology Testing Services Revenue by Type (2027-2032)
- 9.3 Europe Immunology Testing Services Revenue Share by Type (2021-2032)
- 9.4 Europe Immunology Testing Services Revenue by Application (2021-2032)
- 9.4.1 Europe Immunology Testing Services Revenue by Application (2021-2026)
- 9.4.2 Europe Immunology Testing Services Revenue by Application (2027-2032)
- 9.5 Europe Immunology Testing Services Revenue Share by Application (2021-2032)
- 9.6 Europe Immunology Testing Services Revenue by Country
- 9.6.1 Europe Immunology Testing Services Revenue by Country (2021 VS 2025 VS 2032)
- 9.6.2 Europe Immunology Testing Services Revenue by Country (2021-2026)
- 9.6.3 Europe Immunology Testing Services Revenue by Country (2027-2032)
- 9.6.4 Germany
- 9.6.5 France
- 9.6.6 U.K.
- 9.6.7 Italy
- 9.6.8 Russia
- 9.6.9 Spain
- 9.6.10 Netherlands
- 9.6.11 Switzerland
- 9.6.12 Sweden
- 9.6.13 Poland
10 China
- 10.1 China Immunology Testing Services Revenue (2021-2032)
- 10.2 China Immunology Testing Services Revenue by Type (2021-2032)
- 10.2.1 China Immunology Testing Services Revenue by Type (2021-2026)
- 10.2.2 China Immunology Testing Services Revenue by Type (2027-2032)
- 10.3 China Immunology Testing Services Revenue Share by Type (2021-2032)
- 10.4 China Immunology Testing Services Revenue by Application (2021-2032)
- 10.4.1 China Immunology Testing Services Revenue by Application (2021-2026)
- 10.4.2 China Immunology Testing Services Revenue by Application (2027-2032)
- 10.5 China Immunology Testing Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Immunology Testing Services Revenue (2021-2032)
- 11.2 Asia Immunology Testing Services Revenue by Type (2021-2032)
- 11.2.1 Asia Immunology Testing Services Revenue by Type (2021-2026)
- 11.2.2 Asia Immunology Testing Services Revenue by Type (2027-2032)
- 11.3 Asia Immunology Testing Services Revenue Share by Type (2021-2032)
- 11.4 Asia Immunology Testing Services Revenue by Application (2021-2032)
- 11.4.1 Asia Immunology Testing Services Revenue by Application (2021-2026)
- 11.4.2 Asia Immunology Testing Services Revenue by Application (2027-2032)
- 11.5 Asia Immunology Testing Services Revenue Share by Application (2021-2032)
- 11.6 Asia Immunology Testing Services Revenue by Country
- 11.6.1 Asia Immunology Testing Services Revenue by Country (2021 VS 2025 VS 2032)
- 11.6.2 Asia Immunology Testing Services Revenue by Country (2021-2026)
- 11.6.3 Asia Immunology Testing Services Revenue by Country (2027-2032)
- 11.6.4 Japan
- 11.6.5 South Korea
- 11.6.6 India
- 11.6.7 Australia
- 11.6.8 Taiwan
- 11.6.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Immunology Testing Services Revenue (2021-2032)
- 12.2 SAMEA Immunology Testing Services Revenue by Type (2021-2032)
- 12.2.1 SAMEA Immunology Testing Services Revenue by Type (2021-2026)
- 12.2.2 SAMEA Immunology Testing Services Revenue by Type (2027-2032)
- 12.3 SAMEA Immunology Testing Services Revenue Share by Type (2021-2032)
- 12.4 SAMEA Immunology Testing Services Revenue by Application (2021-2032)
- 12.4.1 SAMEA Immunology Testing Services Revenue by Application (2021-2026)
- 12.4.2 SAMEA Immunology Testing Services Revenue by Application (2027-2032)
- 12.5 SAMEA Immunology Testing Services Revenue Share by Application (2021-2032)
- 12.6 SAMEA Immunology Testing Services Revenue by Country
- 12.6.1 SAMEA Immunology Testing Services Revenue by Country (2021 VS 2025 VS 2032)
- 12.6.2 SAMEA Immunology Testing Services Revenue by Country (2021-2026)
- 12.6.3 SAMEA Immunology Testing Services Revenue by Country (2027-2032)
- 12.6.4 Brazil
- 12.6.5 Argentina
- 12.6.6 Chile
- 12.6.7 Colombia
- 12.6.8 Peru
- 12.6.9 Saudi Arabia
- 12.6.10 Israel
- 12.6.11 UAE
- 12.6.12 Turkey
- 12.6.13 Iran
- 12.6.14 Egypt
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst